Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD) Got Higher Bernstein Rating; Grifols S.A. – American Depositary Shares (GRFS) Sellers Decreased By 9.69% Their Shorts

March 12, 2018 - By Evgen Dobrzhanskiy

Grifols S.A. – American Depositary Shares (NASDAQ:GRFS) had a decrease of 9.69% in short interest. GRFS’s SI was 1.01M shares in March as released by FINRA. Its down 9.69% from 1.12M shares previously. With 478,300 avg volume, 2 days are for Grifols S.A. – American Depositary Shares (NASDAQ:GRFS)’s short sellers to cover GRFS’s short positions. The SI to Grifols S.A. – American Depositary Shares’s float is 0.09%. The stock increased 1.41% or $0.3 during the last trading session, reaching $21.61. About 1.01 million shares traded or 72.80% up from the average. Grifols, S.A. (NASDAQ:GRFS) has risen 47.59% since March 12, 2017 and is uptrending. It has outperformed by 30.89% the S&P500.

Among 22 analysts covering Anheuser-Busch InBev (NYSE:BUD), 15 have Buy rating, 2 Sell and 5 Hold. Therefore 68% are positive. Anheuser-Busch InBev has $157 highest and $98.72 lowest target. $123.12’s average target is 6.88% above currents $115.19 stock price. Anheuser-Busch InBev had 47 analyst reports since July 21, 2015 according to SRatingsIntel. As per Wednesday, July 6, the company rating was downgraded by RBC Capital Markets. As per Thursday, January 11, the company rating was maintained by Jefferies. The company was upgraded on Wednesday, August 26 by ING Group. JP Morgan maintained the stock with “Underweight” rating in Thursday, February 15 report. Sterne Agee CRT initiated the stock with “Buy” rating in Tuesday, July 21 report. UBS initiated Anheuser-Busch InBev SA/NV (NYSE:BUD) on Wednesday, September 30 with “Buy” rating. Jefferies maintained Anheuser-Busch InBev SA/NV (NYSE:BUD) on Tuesday, September 19 with “Buy” rating. The firm earned “Underweight” rating on Tuesday, December 5 by JP Morgan. The rating was upgraded by Kepler Cheuvreux on Monday, August 22 to “Buy”. The firm has “Buy” rating given on Wednesday, August 30 by Stifel Nicolaus.

Grifols, S.A., a specialty pharmaceutical company, develops, makes, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company has market cap of $17.96 billion. The firm specializes in providing infusion solutions, nutrition products, and medical devices for use in hospitals and clinics. It has a 36.26 P/E ratio. It operates through four divisions: Bioscience, Diagnostic, Hospital, and Raw Materials and Others.

Among 5 analysts covering Grifols SA (NASDAQ:GRFS), 3 have Buy rating, 1 Sell and 1 Hold. Therefore 60% are positive. Grifols SA had 8 analyst reports since August 17, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Tuesday, January 3 by JP Morgan. As per Wednesday, December 2, the company rating was downgraded by HSBC. The firm has “Buy” rating by Nomura given on Thursday, March 17. Berenberg upgraded Grifols, S.A. (NASDAQ:GRFS) on Tuesday, February 9 to “Buy” rating. Berenberg downgraded the stock to “Hold” rating in Friday, November 20 report. The rating was downgraded by Morgan Stanley to “Underweight” on Monday, January 4.

Investors sentiment decreased to 0.96 in Q3 2017. Its down 0.31, from 1.27 in 2017Q2. It fall, as 30 investors sold Anheuser-Busch InBev SA/NV shares while 138 reduced holdings. 63 funds opened positions while 151 raised stakes. 92.33 million shares or 3.04% more from 89.61 million shares in 2017Q2 were reported. Green Square Cap Ltd invested in 2,380 shares. Highland Capital Management Lc invested 0.25% of its portfolio in Anheuser-Busch InBev SA/NV (NYSE:BUD). Laurion Limited Partnership invested in 49,721 shares or 0.03% of the stock. Raymond James & Assoc stated it has 309,195 shares or 0.07% of all its holdings. Brown Brothers Harriman And Commerce stated it has 7,155 shares. Barrett Asset Mngmt Ltd Llc invested in 100 shares or 0% of the stock. Silvercrest Asset Management Group Ltd Liability Corp has invested 0.05% in Anheuser-Busch InBev SA/NV (NYSE:BUD). Ntv Asset Management Ltd has 11,950 shares for 0.41% of their portfolio. Oppenheimer And accumulated 0.06% or 18,178 shares. Rhode Island-based Parsons Cap Mngmt Inc Ri has invested 0.13% in Anheuser-Busch InBev SA/NV (NYSE:BUD). 44 were accumulated by Of Vermont. Highbridge Cap Management Lc reported 0.2% of its portfolio in Anheuser-Busch InBev SA/NV (NYSE:BUD). Emerging Sovereign Ltd accumulated 14.74% or 296,687 shares. 1832 Asset Mgmt Limited Partnership accumulated 163,718 shares. Synovus Financial Corporation holds 0.01% of its portfolio in Anheuser-Busch InBev SA/NV (NYSE:BUD) for 2,365 shares.

The stock decreased 0.04% or $0.05 during the last trading session, reaching $115.19. About 2.30M shares traded or 21.14% up from the average. Anheuser-Busch InBev SA/NV (NYSE:BUD) has declined 3.55% since March 12, 2017 and is downtrending. It has underperformed by 20.25% the S&P500.

Anheuser-Busch InBev SA/NV, a brewing company, engages in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. The company has market cap of $222.18 billion. It offers a portfolio of approximately 500 beer brands, including Budweiser, Corona, and Stella Artois; Beck??s, Castle, Castle Lite, Hoegaarden, and Leffe; and Aguila, Antarctica, Bud Light, Brahma, Cass, Chernigivske, Cristal, Harbin, Jupiler, Klinskoye, Michelob Ultra, Modelo Especial, Quilmes, Victoria, Sedrin, Sibirskaya Korona, and Skol brands. It has a 43 P/E ratio.